Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

Evolocumab, a cholesterol-lowering drug typically reserved for people with known cardiovascular disease, reduces risk of first-time heart attack and stroke in high-risk patients with diabetes. The ...

The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug, called enlicitide, can reduce the levels of low-density lipoprotein (LDL) cholesterol by 60% ...

Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...

High LDL cholesterol can sneak up on you. It happens slowly over time and causes no symptoms whatsoever. According to a study published in JAMA Cardiology, 42.7% of U.S. adults with high LDL ...

Knowing your blood pressure and cholesterol numbers is a great first step to mitigating your risk for cardiovascular disease. Hearing from your healthcare provider that your numbers are high can be ...